Structured Financing Solutions for the Global Healthcare Industry

We aim to accelerate the development and commercialization of promising healthcare products to create value for our partners and transform patient care.


Who We Are

Oberland Capital is a private investment firm committed to funding innovation across the global healthcare industry. With approximately $3.5 billion in assets under management, Oberland Capital specializes in flexible investment structures customized to meet the specific needs of its partners. Oberland Capital’s broad suite of creative financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity.

Year Founded
Investment Size
Team Members

AUM approximate as of 12/31/2022


Why We Stand Apart

This icon shows a data bar chart. To represent active financial modeling.

Flexible Structures

We work collaboratively with management teams to develop flexible, long-term structures that meet their specific strategic and financial objectives.

This icon shows a global held in a hand. To represent Oberland Capital’s reach.

Global Reach

We have substantial transactional experience across the globe. Our understanding of local legal, tax and accounting frameworks enables us to deploy innovative structures tailored to the specifics of each geography.

This icon shows a people together with a check mark. To represent the right people for the tasks.

Deep Domain Expertise

With a combination of scientific, operational, and financial expertise, our team understands how to design creative capital solutions to address the complexities of product development and commercialization across the life sciences sector.

This icon shows a line chart of data. To represent the financial growth and scale over time.

Meaningful Scale

We provide our partners with meaningful amounts of capital – $50 million to $300+ million – to accelerate organic and inorganic growth opportunities.


Recent Investments


Press & Media